Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ankita Dabla"'
Autor:
Ankita Dabla, Yi Chu Liang, Nusrah Rajabalee, Courtney Irwin, Carolyn G. J. Moonen, Jessie V. Willis, Stefania Berton, Jim Sun
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT Macrophage surface receptors are critical for pathogen defense, as they are the gatekeepers for pathogen entry and sensing, which trigger robust immune responses. TREM2 (triggering receptor expressed on myeloid cells 2) is a transmembrane su
Externí odkaz:
https://doaj.org/article/3fbff13b69614e4ea3be03628ae8cd32
Autor:
Suresh Kumar, Mehak Zahoor Khan, Neha Khandelwal, Chen Chongtham, Biplab Singha, Ankita Dabla, Debashree Behera, Archana Singh, Balasubramanian Gopal, G. Aneeshkumar Arimbasseri, Siddhesh S. Kamat, Vinay Kumar Nandicoori
Publikováno v:
mBio, Vol 13, Iss 3 (2022)
ABSTRACT Mycobacterium tuberculosis encodes ~200 transcription factors that modulate gene expression under different microenvironments in the host. Even though high-throughput chromatin immunoprecipitation sequencing and transcriptome sequencing (RNA
Externí odkaz:
https://doaj.org/article/463f904daf694b2c99ca67ae6b16d618
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Tuberculosis is a deadly, contagious respiratory disease that is caused by the pathogenic bacterium Mycobacterium tuberculosis (Mtb). Mtb is adept at manipulating and evading host immunity by hijacking alveolar macrophages, the first line of defense
Externí odkaz:
https://doaj.org/article/54f324cccd8b4d94b9260c1bb88e3445
Autor:
Parijat Kundu, Richa Misra, Saba Naz, Yogendra Singh, Andaleeb Sajid, Ulf Gerth, Ankita Dabla, Anshika Singhal, Suresh Kumar, Virginie Molle, Mohita Gaur, Kriti Sharma, Gunjan Arora, Vinay Kumar Nandicoori, Richa Virmani, Jacob Nellissery, Anand Swaroop
Publikováno v:
Biochemical Journal
Post-translational modifications such as phosphorylation, nitrosylation, and pupylation modulate multiple cellular processes in Mycobacterium tuberculosis. While protein methylation at lysine and arginine residues is widespread in eukaryotes, to date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbcfcb5c534c49b07498c887f71a1348
https://doi.org/10.1042/bcj20200455
https://doi.org/10.1042/bcj20200455
Autor:
Santosh Kumar, Anjna Kumari, Mona Singh, Ved Prakash Dwivedi, Ashima Bhaskar, Debprasad Chattopadhyay, Suresh Kumar, Ankita Dabla, Vinod Yadav, Shivam Chaturvedi
Publikováno v:
International immunopharmacology. 87
The currently available anti-tuberculosis treatment (ATT) comprises exclusively of anti-bacterial drugs, is very lengthy, has adverse side effects on the host and leads to the generation of drug-resistant variants. Therefore, a combination therapy di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73bd17742894f563b1028ad0a06bf72
https://pubmed.ncbi.nlm.nih.gov/32693356
https://pubmed.ncbi.nlm.nih.gov/32693356